AU4427000A - Pharmaceutical compositions comprising apocodeine and/or its derivatives - Google Patents
Pharmaceutical compositions comprising apocodeine and/or its derivatives Download PDFInfo
- Publication number
- AU4427000A AU4427000A AU44270/00A AU4427000A AU4427000A AU 4427000 A AU4427000 A AU 4427000A AU 44270/00 A AU44270/00 A AU 44270/00A AU 4427000 A AU4427000 A AU 4427000A AU 4427000 A AU4427000 A AU 4427000A
- Authority
- AU
- Australia
- Prior art keywords
- apc
- derivatives
- male
- pct
- adhesive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IE990389 | 1999-05-13 | ||
IE990389 | 1999-05-13 | ||
PCT/IE2000/000065 WO2000069416A1 (en) | 1999-05-13 | 2000-05-12 | Pharmaceutical compositions comprising apocodeine and/or its derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4427000A true AU4427000A (en) | 2000-12-05 |
Family
ID=11042062
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU44270/00A Abandoned AU4427000A (en) | 1999-05-13 | 2000-05-12 | Pharmaceutical compositions comprising apocodeine and/or its derivatives |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1175206A1 (no) |
JP (1) | JP2002544221A (no) |
AU (1) | AU4427000A (no) |
CA (1) | CA2371551A1 (no) |
MX (1) | MXPA01011480A (no) |
NO (1) | NO20015519L (no) |
WO (1) | WO2000069416A1 (no) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6506765B2 (en) * | 2000-04-07 | 2003-01-14 | Tap Pharmaceutical Products, Inc. | Apomorphine derivatives and methods for their use |
SE0002934D0 (sv) | 2000-08-17 | 2000-08-17 | Axon Biochemicals Bv | New aporphine esters and in their use in therapy |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4806341A (en) * | 1985-02-25 | 1989-02-21 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration |
FI873429A (fi) * | 1986-08-18 | 1988-02-19 | Houston Biotechnology | Oftalmologiska kompositioner foer behandling av nervdegenerationer. |
EP0914097B1 (en) * | 1996-03-12 | 2002-01-16 | Alza Corporation | Composition and dosage form comprising opioid antagonist |
-
2000
- 2000-05-12 EP EP00925551A patent/EP1175206A1/en not_active Withdrawn
- 2000-05-12 WO PCT/IE2000/000065 patent/WO2000069416A1/en not_active Application Discontinuation
- 2000-05-12 AU AU44270/00A patent/AU4427000A/en not_active Abandoned
- 2000-05-12 CA CA002371551A patent/CA2371551A1/en not_active Abandoned
- 2000-05-12 MX MXPA01011480A patent/MXPA01011480A/es unknown
- 2000-05-12 JP JP2000617875A patent/JP2002544221A/ja active Pending
-
2001
- 2001-11-12 NO NO20015519A patent/NO20015519L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20015519D0 (no) | 2001-11-12 |
EP1175206A1 (en) | 2002-01-30 |
MXPA01011480A (es) | 2002-06-04 |
CA2371551A1 (en) | 2000-11-23 |
WO2000069416A1 (en) | 2000-11-23 |
JP2002544221A (ja) | 2002-12-24 |
NO20015519L (no) | 2002-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2533211B2 (ja) | 全身的経皮投与用医薬組成物 | |
US20040202705A1 (en) | Transdermal administration of huperzine | |
WO2007120868A2 (en) | Bioavailability enhancement of lipophilic drug by use solvent system | |
US20120309823A1 (en) | Percutaneous absorption preparations | |
JP2540019B2 (ja) | 医薬組成物 | |
US20120077836A1 (en) | Methods of administering (4ar,10ar)-1-n-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo [g] quinoline-6,7-diol and related compounds across the oral mucosa, the nasal mucosa or the skin and pharmaceutical compositions thereof | |
US20080176913A1 (en) | Transdermal compositions of pramipexole having enhanced permeation properties | |
AU764025B2 (en) | Transdermal patch and topical compositions comprising propylnorapomorphine | |
WO2021098791A1 (zh) | 一种含有美金刚的透皮贴剂 | |
NO320050B1 (no) | Transmukosale formuleringer av levosimendan og anvendelse derav til fremstilling av faramasoytisk preparat. | |
AU4427000A (en) | Pharmaceutical compositions comprising apocodeine and/or its derivatives | |
CN112107561B (zh) | 含有壳聚糖的药物制剂、药物透皮贴剂及其制备方法 | |
CN115475152A (zh) | 氟比洛芬的外用制剂及其制备方法 | |
Walters et al. | Dermal and Transdermal Drug Delivery Systems: An Overview and Recent Advancements | |
CN112057436A (zh) | 含有脂质的药物制剂、药物透皮贴剂及其制备方法 | |
JP3841628B2 (ja) | 経皮吸収剤 | |
Kruti et al. | Novel Drug Delivery Approach: Transdermal Drug Delivery System–A Review | |
Walters et al. | 1 Dermal Drug Delivery and Transdermal Systems | |
MXPA01000527A (en) | Transdermal patch and topical compositions comprising propylnorapomorphine | |
Krishnarajan et al. | RECENT APPROACHES OF TRANSDERMAL DRUG DELIVERY SYSTEM: A REVIEW | |
AU2013206198A1 (en) | Methods of administering (4aR,10aR)-1-n-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinoline-6,7-diol and related compounds across the oral mucosa, the nasal mucosa or the skin and pharmaceutical compositions thereof | |
JP2017007994A (ja) | 経皮吸収型製剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1 | Application lapsed section 142(2)(a) - no request for examination in relevant period |